Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Medication-Use Evaluation of Caspofungin in Intensive Care Units of Alzahra Hospital, Isfahan, Iran, in Year 2015 Publisher



Pourmohammad J1 ; Abbasi S2 ; Farsaei S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Anesthesiology, School of Medicine AND Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2018


Abstract

Background: Medication-use evaluation (MUEs) is analyzing the drug usage pattern in a treatment center and comparing it to the standards. Therefore, medication-use evaluation studies are considered to be effective and useful. Caspofungin is the first of a new class of antifungals, the echinocandins. It is used for treatment of resistant fungal infections like invasive aspergillosis, candidiasis, and empiric antifungal therapy in neutropenic fever. This study aimed to assess the pattern of the consumption of caspofungin in patients hospitalized in an intensive care unit in Isfahan, Iran in 2015, and to compare the results with the standard amounts in literature. Methods: This was a descriptive and cross-sectional (retrospective) study conducted in Alzahra hospital, Isfahan, Iran, based on the files of the patients hospitalized in the intensive care units in a six-month period in year 2015. 49 patients hospitalized in the intensive care units in this time period, had received caspofungin. The information was gathered by reviewing the patients’ medical records. Due to the specific objectives of the study, the extracted information was compared to the defined standards to be presented as percentages. Findings: The most frequent uses of this drug was for treatment of pneumonia (38.8%), sepsis (32.7%), peritonitis (20.4%), and fever and neutropenia (1.8%). The duration of treatment differed from 1 to 56 days. The administered dose of the drug was similar to the model in 92% of the cases. Decreased hemoglobin and hematocrit were the most frequent recorded drug side effects (73.4%). Conclusion: The cases of drug administration was similar to the standard model; but the dosage had a considerable difference, and the duration of use was significantly longer than the standard model. © 2018, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Epidemiologic and Antifungal Susceptibility Profile of Candiduria Among Patients Hospitalized in the Nephrology and Intensive Care Unit Wards, Tehran, Iran, Jundishapur Journal of Microbiology (2022)
2. Species Distribution and Antifungal Susceptibility Profile of Candida Isolates From Blood and Other Normally Sterile Foci From Pediatric Icu Patients in Tehran, Iran, Medical Mycology (2020)
3. Fungal Presence and Health Implications in Hospital Water Systems, International Journal of Environmental Health Research (2024)
4. Invasive Fungal Infection in Febrile Patients With Hematologic Malignancies Undergoing Chemotherapy in Iran, Endocrine, Metabolic and Immune Disorders - Drug Targets (2019)
5. In Vitro Antifungal Susceptibility Profile of Miltefosine Against a Collection of Azole and Echinocandins Resistant Fusarium Strains, Journal of Fungi (2022)
6. Treatment of Invasive Fungal Infection: Recommendations From Scientific Leaders' Meeting on November 3Rd, 2011 Tehran - Iran, Iranian Journal of Clinical Infectious Diseases (2011)
7. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin Against Candida Species Compared to Fluconazole, Journal of Isfahan Medical School (2015)
8. Antifungal Effect of Atorvastatin Against Candida Species in Comparison to Fluconazole and Nystatin, Medicine and Pharmacy Reports (2019)
Experts (# of related papers)
View all Related Experts
Rasoul Mohammadi (13)
Seyed Hossein Mirhendi Esfahani (8)
Other Related Docs
9. In Vitro Activities of Six Antifungal Drugs Against Candida Glabrata Isolates: An Emerging Pathogen, Jundishapur Journal of Microbiology (2016)
10. The Effect of Garlic Pills on the Results of Cultured Samples From Peripheral, Urinary, and Central Catheters and Inflammatory Factors in Patients in Intensive Care Unit (Icu), Journal of Isfahan Medical School (2018)
11. In Vitro Antifungal Susceptibility Profile of Iranian Fusarium Isolates: Emphasising on the Potent Inhibitory Effect of Efinaconazole Compared to Other Drugs, Mycoses (2023)
12. Comparison of the Therapeutic Effects of Garcin® and Fluconazole on Candida Vaginitis, Singapore Medical Journal (2015)
13. Epidemiology and Antifungal Susceptibility of Candida Species Isolated From 10 Tertiary Care Hospitals in Iran, Microbiology Spectrum (2022)
14. The Survey of Fungal Wounds Infections in Burn Patients in Isfahan, Iran, Journal of Isfahan Medical School (2017)
15. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)
16. Nosocomial Urinary Tract Infections in a Tertiary Hospital; Preliminary Study of Antibiotics Susceptibility Testing and Pathogen Types, Anti-Infective Agents (2024)
17. Microbial Epidemiology of Candidaemia in Neonatal and Paediatric Intensive Care Units at the Children's Medical Center, Tehran, Mycoses (2018)
18. Candida Palmioleophila Candidemia and Bacterial Co-Infection in a 3-Month-Old Infant With Biliary Atresia, Frontiers in Cellular and Infection Microbiology (2023)
19. Premedication Drugs' Evaluation and Incidence of Infusion-Related Reactions in Patients Receiving Amphotericin B, Tehran University Medical Journal (2020)
20. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated From Clinical Samples, Jundishapur Journal of Microbiology (2017)
21. The Frequency of Candiduria in Hospitalized Patients at Nephrology Department, Labbafinejad Hospital, Tehran, Iran, Journal of Isfahan Medical School (2017)
22. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)
23. Antibiotic Use During the First 6 Months of Covid-19 Pandemic in Iran: A Large-Scale Multi-Centre Study, Journal of Clinical Pharmacy and Therapeutics (2022)
24. The Frequency of Drug Interactions in Patients in the Intensive Care Units of Alzahra Hospital, Isfahan, Iran, Journal of Isfahan Medical School (2017)
25. Second-Year Outcomes of Implementing Antimicrobial Stewardship Program in a Tertiary Pediatric Hospital, Jundishapur Journal of Microbiology (2021)
26. In Vitro Antifungal Susceptibility Pattern of Candida Species Isolated From Gastroesophageal Candidiasis, Gastroenterology and Hepatology from Bed to Bench (2021)
27. Catheter-Associated Blood Stream Infections Due to Candida Pararugosa in a Patient With Acute Myeloid Leukemia: A Case Report, Brazilian Journal of Microbiology (2023)
28. Tazocin (Piperacillin-Tazobactam) Susceptibility Pattern in Nosocomial Infections, Journal of Kerman University of Medical Sciences (2013)
29. Antifungal Susceptibility Testing of Candida Species Isolated From the Immunocompromised Patients Admitted to Ten University Hospitals in Iran: Comparison of Colonizing and Infecting Isolates, BMC Infectious Diseases (2017)
30. Cross-Sectional Study of Candidemia From Isfahan, Iran: Etiologic Agents, Predisposing Factors, and Antifungal Susceptibility Testing, Journal of Research in Medical Sciences (2021)
31. Frequency of Candida Species Isolated From Patients in Children’S Medical Center, Tehran, Iran, Archives of Pediatric Infectious Diseases (2018)
32. In Vitro Activity of Juglone (5-Hydroxy-1,4-Naphthoquinone) Against Both Fluconazole-Resistant and Susceptible Candida Isolates; [Actividad in Vitro De Juglona (5-Hidroxi-1,4-Naftoquinona) Contra Aislamientos De Candida Resistentes Y Sensibles a Fluconazol], Revista Iberoamericana de Micologia (2022)
33. Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia in Intensive Care Units in Isfahan, Iran, Current Medical Mycology (2022)
34. The Effect of Infectious Disease Specialists Deployment Plan on Using Antibiotics in Alzahra Hospital, Isfahan, Iran, Journal of Isfahan Medical School (2014)
35. Candida Urinary Tract Infection Among Icu Patients in Isfahan, Iran, Archives of Clinical Infectious Diseases (2019)
36. Antifungal Effect of Atorvastatin in Comparison With Fluconazole on Candida Species Isolated From Patients Undergoing Head‑And‑Neck Radiotherapy, Dental Research Journal (2024)
37. Multicenter Study of Susceptibility of Aspergillus Species Isolated From Iranian University Hospitals to Seven Antifungal Agents, Microbiology Spectrum (2022)
38. Serum Procalcitonin Levels of Patients With Candidemia Hospitalized in Intensive Care Units, Journal of Medical Sciences (Taiwan) (2018)